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Abstract
Background: Tityus serrulatus scorpion venom (TsV) contains toxins that act on K+ and Na+ channels and account
for the venom’s toxic effects. TsV can activate murine peritoneal macrophages, but its effects on human
lymphocytes have been poorly investigated. Considering that lymphocytes may play an important role in
envenomation, we assessed whether TsV affects the expression of phenotypic (CD3, CD4, and CD8) and activation
(CD69, CD25, and HLA-DR) markers, cell proliferation, and cytokine production in peripheral blood mononuclear
cells.
Methods: Cytotoxicity of TsV was evaluated via the MTT assay. Cell proliferation, expression of phenotypic and
activation markers, and release of cytokines were assessed using flow cytometry, after treatment with non-cytotoxic
concentrations of TsV. The combined use of carboxyfluorescein diacetate succinimidyl ester and monoclonal
antibodies against phenotypic and activation markers enabled us to simultaneously assess cell proliferation extent
and cell activation status, and to discriminate among cell subpopulations.
Results: TsV at concentrations of 25 to 100 μg/mL were not cytotoxic towards peripheral blood mononuclear cells.
TsV did not induce significant changes in lymphocyte subpopulations or in the expression of activation markers on
CD4+ and CD8+ T cells. TsV inhibited the phytohemagglutinin-stimulated lymphocyte proliferation, particularly in
the CD8+ CD25+ T lymphocyte subset. TsV alone, at 50 and 100 μg/mL, did not induce peripheral blood
mononuclear cell proliferation, but elicited the production and release of IL-6, a proinflammatory cytokine that plays
an important role in innate and adaptive immune responses.
Conclusions: TsV is a potential source of molecules with immunomodulatory action on human T lymphocytes.
Keywords: Immunomodulation, Immunophenotyping, T lymphocyte, Cell proliferation, Cytokine, Tityus serrulatus
venom
Background
Scorpions from the family Buthidae are responsible for
the majority of worldwide envenomations, especially in
South Asia, the Middle East, Central and South America,
and North Africa [1, 2]. Tityus is one genus of this family,
of which Tityus serrulatus is the most dangerous species –
it causes serious envenomation that may provoke fatalities,
the majority of the victims are children [3–7].
Scorpion venom is composed of numerous toxins,
mostly of peptides and neurotoxins, which act by deregu-
lating cell membrane ion channels. Such toxins may cause
pain, deregulation of cardiovascular and autonomic
nervous systems, vomiting, abdominal pain, stimulation of
peripheral nervous system, neuromuscular excitation,
among other deleterious effects in humans [8].
Massive activation of the immune system seems also to
participate in the pathogenesis of T. serrulatus envenom-
ation. The plasma levels of NO and cytokines – such as
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interleukin-1 (IL-1), IL-6, IL-8 and interferon-γ (IFN-γ)
produced by immune cells – are increased in patients pre-
senting moderate or severe T. serrulatus envenomation,
and correlate with the severity of envenomation [9]. The
participation of proinflammatory cytokines in the moder-
ate and severe envenomation pathophysiology indicates
that these patients may benefit from treatment with
glucocorticoids.
Recent studies reported that the venom of T. serrulatus
and its toxins activate murine macrophages, which are
critical cells for the immune response because they par-
ticipate in humoral and cellular responses [10–15]. How-
ever, the effect of Tityus serrulatus scorpion venom (TsV)
on human lymphocytes remains to be investigated. Con-
sidering that TsV contains several toxins that act on mem-
brane K+ channels, and that these channels are involved
in the regulation of cellular functions, in the present study
we examined whether TsV interferes in peripheral blood
mononuclear cell (PBMC) cytokine production, as well as
in T lymphocyte phenotype, proliferation, and expression
of activation markers.
Methods
Source and preparation of venom
TsV was obtained from the serpentarium of the Ribeirão
Preto Medical School, University of São Paulo, Brazil, by
using the electrical stimulation method with the minimal
voltage required (− 12 V) [16].
Lyophilized TsV (4 mg) was diluted with 10 mL of
sterile distilled water and fractionated by centrifugation
(10,015 × g, 4 °C, 10 min), yielding an insoluble and
non-toxic fraction composed of mucoproteins and mem-
brane debris. The soluble part was rich in basic neuro-
toxic proteins, but also contained various enzymes and
organic (lipids, carbohydrates, nucleosides, free amino
acids) and inorganic (ions) compounds. Protein concen-
trations in crude soluble venom were determined by ab-
sorbance readings at 280 nm using a NanoDrop 2000
spectrophotometer (Thermo Scientific, Wilmington,
DE, USA) and the extinction coefficient of the soluble
venom [17]:
ε1 mg=mL280 nm ¼ 1:65
Peripheral blood mononuclear cell (PBMC) isolation and
culture
PBMC were isolated from venous blood of 20 healthy
adult volunteers (7 males and 13 females, 20–40 years
old) via the Ficoll-Hypaque (Hystopaque®-1077; Sigma-
Aldrich, USA) discontinuous density centrifugation
method. PBMC were washed twice, suspended in
RPMI 1640 medium (GIBCO®, USA) to a concentra-
tion of 5 × 106 cells/mL. Cells were cultured in RPMI
with phytohemagglutinin (PHA; 2 μg/mL; Sigma-
Aldrich, USA) and/or TsV (25, 50, and 100 μg/mL) at
37 °C and under 5 % CO2, during the proliferation
assay (96 h) and before the immunophenotyping assay
(24 h). The Human Research Ethics Committee at
FCFRP-USP approved the research protocol, regis-
tered under number CEP/FCFRP 166.
Cytotoxicity evaluation
The cytotoxic activity of TsV was evaluated using the
MTT method described by Mosmann [18]. PBMC
(5 × 105 cells/well) were cultured in 96-well plates in
RPMI 1640 complete culture medium containing
10 % fetal calf serum (FCS) in the presence of TsV
(12.5; 25.0; 50.0; 62.5; 100.0; 125.0; 250.0; 500.0;
1000.0; 2000.0 μg/mL) or cyclophosphamide (Cyclo;
25 mg/mL; positive control; Sigma-Aldrich, USA) pre-
viously diluted in culture medium, for 24 h at 37 °C,
and under 5 % CO2. Next, 20 μL of MTT (Sigma-Aldrich,
USA) solution at 5 mg/mL was added to each well, and
the plates were incubated for 4 h, at 37 °C, and under 5 %
CO2. After incubation, the precipitated formazan crystals
were dissolved with 200 μL of 20 % SDS (sodium dodecyl-
sulfate), and absorbance was recorded at 570 nm. Absorb-
ance values recorded for untreated cells (negative control)
represent 100 % of PBMC viability, and were used as refer-
ence to calculate the percentage of cell viability in the
presence of each sample concentration.
Immunophenotyping of lymphocyte subsets and
activation markers
Flow cytometry analysis was performed to identify and
quantify lymphocyte subpopulations (CD3-FITC, CD4-PE,
and CD8-PE monoclonal antibodies), and to measure the
levels of cellular activation markers expression (CD69,
CD25, and HLA-DR monoclonal antibodies conjugated
with APC) (Becton-Dickinson, USA).
PBMC (2 × 105 cells per well) were cultured with TsV
(25; 50; 100 μg/mL) for 24 h at 37 °C, and under 5 %
CO2. Cells were collected, suspended to a concentration
of 1 × 106 cells in 100 μL of FACS buffer (phosphate
buffered saline – PBS, with 10 % FCS and 1 % sodium
azide), and incubated with 1 μL of monoclonal anti-
bodies at the following concentrations (mg/mL):
0.0031(CD4); 0.0125 (CD8); 0.012 (CD25); 0.2 (CD69);
0.05 (HLA-DR); and 0.1 (CD3), for 30 min at 4 °C, in
the dark. Then, the cells were washed with PBS and sus-
pended in 100 μL of PBS-FCS.
A total of 30,000 events per tube was acquired on the
flow cytometer (FACSCanto, Becton-Dickinson, USA),
the lymphocyte gate was selected according to its for-
ward and side scatter distribution, and further analyzed
with the aid of the software FACSDiva (Becton-Dickinson,
USA). The results were expressed as percentages of
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stained cells. Additional file 1 depicts representative
forward/side scatter dot-plots of human PBMC
treated with TsV.
Cell proliferation assay
The use of carboxyfluorescein diacetate succinimidyl
ester (CFSE) in combination with monoclonal antibodies
against phenotypic and activation markers enabled the
concomitant determination of cell proliferation and acti-
vation status and discrimination of cell subpopulations.
PBMC were centrifuged, suspended to the concentra-
tion of 5 × 106 cells/mL in PBS containing 0.1 % human
albumin, and labeled with CFSE (2.5 μM; Molecular
Probes, USA) for ten minutes at 37 °C. The labeling
process was stopped by addition of five volumes of ice-
cold RPMI 1640 containing 10 % FCS (RPMI-FCS)
followed by incubation for five minutes in an ice bath, in
the dark. The cells were washed three times with 20 mL
of RPMI-FCS, and further suspended in the same
medium.
PBMC were plated in 96-well plates (5 × 105 cells/well)
and cultured with PHA (2 μg/mL) and/or TsV(25, 50, or
100 μg/mL) for 96 h at 37 °C, and under 5 % CO2. The
cells (1 × 106) were transferred to flow cytometry tubes
and labeled with 2 μL of the following monoclonal anti-
bodies: anti-CD3/PerCP (Peridinin-chlorophyll-protein
complex); anti-CD8, or anti-CD4 PE; anti-CD25, anti-
HLA-DR, or anti-CD69 APC (Becton-Dickinson, USA).
A total of 30,000 events per tube was acquired on the
flow cytometer (FACSCanto, Becton-Dickinson, USA)
and analyzed with the aid of the software FACSDiva
(Becton-Dickinson, USA). The lymphocyte gate was set
on light-scatter properties (forward scatter vs. side scat-
ter). The results were expressed as percentages of
stained cells.
Cytokine quantification
The levels of tumor necrosis factor-α (TNF-α), IL-2, IL-4,
IL-6, IL-10, IL-17, and IFN-γ in culture supernatants of
PBMC (1.0 × 105 cells) treated with PHA (2 μg/mL) and/
or TsV (25, 50, and 100 μg/mL) for 96 h were quantified
by flow cytometry, using the assay kit Cytometric
Bead Array (CBA) Human Th1/Th2/Th17 Cytokine
(BD Biosciences, USA) according to the manufac-
turer’s instructions. The samples were analyzed on a
FACSCanto cytometer with the aid of the CBA ana-
lysis software FCAP Array (version 1.01; Becton-
Dickinson, USA). The cytokine concentration was
expressed as pg/mL.
Statistical analysis
The results were expressed as mean ± standard error of
the mean (SEM). Statistical analysis was performed by
one-way analysis of variance (ANOVA) followed by the
Tukey’s test, using the software Graph Pad Prism 5. Sig-
nificance was defined as p < 0.05.
Results
TsV at lower concentrations is not cytotoxic towards
PBMC
We used the MTT assay to examine whether TsV is cyto-
toxic towards PBMC. Compared with untreated cells, TsV
at concentrations of 500, 1000, and 2000 μg/mL reduced
cell viability by 12.7, 22.2, and 23.7 %, respectively. TsV
was not cytotoxic towards PBMC at concentrations lower
than 250 μg/mL (Fig. 1). Based on these results, we se-
lected the TsV concentrations of 25, 50, and 100 μg/mL
for further experiments.
TsV does not induce changes in T lymphocyte
subpopulations and in the expression of PBMC activation
markers
After 24 h of culture, TsV at concentrations of 25, 50,
and 100 μg/mL did not induce significant changes in
TCD3+CD4+ and CD3+CD8+ lymphocyte subpopula-
tions, and did not modulate the expression of three acti-
vation markers – CD69, CD25 and HLA-DR – in PBMC
(Fig. 2).
TsV inhibits the proliferation of CD8+CD25+ T
lymphocytes
In PBMC previously stimulated with PHA, the 96-h
treatment with TsV at 25, 50 or 100 μg/mL reduced the
Fig. 1 Effect of Tityus serrulatus scorpion venom (TsV) on peripheral
blood mononuclear cell (PBMC) viability. PBMC (5 × 105 cells/well)
were treated with different concentrations of TsV for 24 h, and cell
viability was assessed by the MTT method. Cyclophosphamide
(Cyclo; 25 mg/mL) was used as positive control. Results are
expressed as mean (± SEM) percentage of cell viability calculated
in relation to untreated cells (n = 6 experiments). *p < 0.05 and
***p < 0.001 vs. untreated cells
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Fig. 2 (See legend on next page.)
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percentage of CD8+CD25+ lymphocytes by 35.7, 45.5,
and 53.5 %, respectively, i.e. in a concentration-
dependent manner (Fig. 3). These values were statisti-
cally different from the respective control (PHA) at TsV
concentrations of 50 and 100 μg/mL (Fig. 3). In contrast,
TsV did not alter either T lymphocyte proliferation ex-
tent or the percentage of CD3+CD4+ and CD3+CD4
+HLA-DR+ lymphocyte subsets in non-stimulated
PBMC, as compared with PHA- and PHA + TsV-stimu-
lated PBMC (data not shown).
TsV induces IL-6 release by PBMC
TsV induced IL-6 release by PBMC in a concentration-
dependent manner. The IL-6 levels in culture superna-
tants of non-stimulated PBMC were significantly in-
creased at TsV concentrations of 50 and 100 μg/mL
(p < 0.05 and p < 0.01, respectively), compared with
the respective control (CFSE) (Fig. 4). TsV did not
alter IL-6 release in PHA-stimulated cells, or the
release of other cytokines (IL-2, IL-4, IL-10, IL-17,
IFN-γ, and TNF-α) by non-stimulated and PHA-
stimulated PBMC (data not shown).
Discussion
In Brazil, the yellow scorpion T. serrulatus is the most
dangerous Buthidae species and the main cause of ser-
ious accidents [4]. Its venom (TsV) contains toxins that
act on K+ and Na+ channels, a property that accounts
for great portion of the venom’s toxic effects. Several stud-
ies have reported that scorpion venoms and toxins, in-
cluding TsV, elicit macrophage activation [11–13, 15, 19].
TsV and Ts1 bind Toll-like receptors to mediate cytokine
and lipid mediator production [14]. Such reports have
helped to elucidate how inflammatory mediators are pro-
duced after envenomation.
To date, very little is known about the direct effect of
scorpion venoms on human lymphocyte functions. As
lymphocytes have membrane K+ channels and TsV con-
tains toxins that interact with these channels, we hypothe-
sized that TsV and its toxins could affect lymphocyte
functions mediated by the activity of K+ channels, such as
PHA-induced cell proliferation [11, 20–22].
Cell stimulation by pathogens in infectious and inflam-
matory processes and by mitogens induces the expres-
sion of activation markers in T, B, and NK cells. PHA, a
commonly used mitogen, is a plant lectin that binds to
TCR and activates T lymphocytes [23]. In the present
study, we examined the expression of very early (CD69),
middle-to-late (CD25), and late (HLA-DR) T cell surface
activation markers. CD69 expression can be detected
within 1 to 2 h after T cell stimulation [24]. It can initiate
tyrosine kinase and calcium flux activity, and transcription
of IL-2 and TNF-α [25]. The expression of CD25 (the α-
chain of the IL-2 receptor) and HLA-DR (a human class
II major histocompatibility complex antigen) increases
progressively after 24 h of stimulation with PHA [26].
After establishing the TsV concentrations and incu-
bation time with PBMC, we examined whether TsV
alters the percentage of T lymphocytes, and the ex-
tent of CD4+ and CD8+ T cell proliferation. In the
presence of TsV, the percentage of T lymphocytes
(data not shown), as well as the percentage of CD3
+CD4+ and CD3+CD8+ lymphocyte subpopulations ex-
pressing CD69, CD25, and HLA-DR were similar to
the untreated controls. However, maximum expression
of some activation markers, especially CD25 and
Fig. 3 Percentage of CD8+ T lymphocytes expressing CD25.
Peripheral blood mononuclear cells (PBMC; 5 × 106cells/mL) were
labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE;
2.5 μM) and cultured with Tityus serrulatus scorpion venom (TsV; 25,
50, and 100 μg/mL) alone or in combination with
phytohemagglutinin (PHA; 2 μg/mL) for 96 h at 37 °C, and under
5 % CO2. Then, PBMC were collected, labeled with anti-CD3/PerCP,
anti-CD8/PE, and anti-CD25/APC monoclonal antibodies, and further
analyzed by flow cytometry. CFSE: CFSE-stained cells cultured in
RPMI; PHA: PHA-stimulated cells (positive control); 25, 50, 100: cells
incubated with 25, 50, and 100 μg/mL TsV, respectively; PHA+ 25, PHA
+ 50, PHA+ 100: cells incubated with PHA plus 25, 50 and 100 μg/mL
TsV, respectively. Each column represents the mean ± SEM of five
experiments.*p< 0.05 vs. PHA
(See figure on previous page.)
Fig. 2 Lymphocyte subsets and their expression levels of activation markers after TsV treatment. Peripheral blood mononuclear cells (2 × 105 cells)
were cultured with Tityus serrulatus scorpion venom (TsV; 25, 50, and 100 μg/mL) or phytohemagglutinin (PHA; 2 μg/mL; positive control) for
24 h, at 37 °C, under 5 % CO2, and further stained with monoclonal antibodies to simultaneously detect CD3
+CD4+ (a, b, c) and CD3+CD8+
(d, e, f) T lymphocyte subsets, and the expression of three activation markers: CD69 (a, d), CD25 (b, e), and HLA-DR (c, f). Control: untreated cells.
Data are expressed as mean ± SEM of six experiments. ***p <0.001 vs. control
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HLA-DR, may occur later. It suggests that the PBMC
culture periods used (24 h and 96 h) were not suffi-
cient to detect significant alterations in the expression
level of these markers. To confirm this hypothesis, it
is necessary to perform additional experiments using
longer culture times. Another possibility is to use
higher TsV concentrations to better evaluate its action
on the expression of lymphocyte activation markers.
To assess lymphocyte proliferation, we selected CFSE
due to its compatibility with several other fluoro-
chromes, which enabled us to simultaneously evaluate
several parameters including the percentage of activated
cells and proliferation of distinct populations of activated
cells, using multi-color flow cytometry [27]. With the
aid of this technique, we found that TsV at 50 and
100 μg/mL significantly decreased the percentage of
CD8+CD25+ T cells in PHA-stimulated PBMC (Fig. 3).
Considering that ion channels participate in an early
stage of cell activation by PHA, it is possible that toxins
that exist in TsV act on ions channels in CD8+CD25+ T
cells and thereby impair the action of PHA on these cells
[22]. It is well documented that ion channels play im-
portant roles in the activation and proliferation of
lymphocytes, as well as in the production of cytokines
[20, 28, 29]. Blockage of the K+ channel Kv1.3 inhibits
mitogen-induced T cell proliferation, protein synthesis
and IL-2 production [20].
Cytokines are produced during the effector phases of
innate and acquired immune responses and regulate im-
mune and inflammatory responses [30, 31]. Besides the
knowledge that TsV and its toxins are potent inducers of
cytokine and lipid mediator production in vitro and in
vivo [11–15, 19], little is known about the effect of TsV
on the production of cytokines by human PBMC. We
measured the levels of various cytokines – IL-2, IL-4,
IL-6, IL-10, IL-17, IFN-γ and TNF-α – in the super-
natant of PBMC cultures after 96 h of treatment with
PHA and/or different concentrations of crude TsV.
Compared with untreated cells, TsV at 50 and
100 μg/mL significantly increased IL-6 release in non-
stimulated cells (p < 0.05 and p < 0.01, respectively)
(Fig. 4). In contrast, TsV did not alter the PHA-
induced IL-6 production by PBMC. Our results par-
tially agree with those reported by several in vitro
and in vivo studies [11–15, 19]. TsV fractions stimu-
late the macrophage production of proinflammatory
cytokines such as TNF-α, IL-1, and IL-6 [32]. TsV
and the toxins Ts1 and Ts6 stimulate the production
of NO, IL-6, and TNF-α in J774.1 cells [12]. When
inoculated in mice, Ts2 and Ts6 induce the produc-
tion of the proinflammatory cytokines IL-6, TNF-α,
IL-1β, and IFN-γ, and the lipid mediators prostaglan-
din E2 and leukotriene B4 [13]. Several authors have
reported that IL-6 levels are increased after envenom-
ation in humans [9, 33–35].
To the best of our knowledge, this is the first study that
shows immunomodulatory actions of TsV on human T
lymphocytes. Taken together, our results suggest that TsV
is a potential source of molecules with immunomodula-
tory effects on these cells, and should stimulate further
Fig. 4 Interleukin-6 (IL-6) release by PBMC treated with Tityus serrulatus scorpion venom (TsV) for 96 h. Peripheral blood mononuclear cells (PBMC;
5.0 × 105 cells) were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE; 2.5 μM) and cultured with TsV (25, 50, and 100 μg/mL)
alone or in combination with phytohemagglutinin (PHA; 2 μg/mL) for 96 h. The levels of IL-6 in culture supernatants were determined by flow
cytometry. CFSE: CFSE-stained cells cultured in RPMI 1640; PHA: PHA-stimulated cells (positive control); 25, 50, 100: cells incubated with 25, 50,
and 100 μg/mL TsV, respectively; PHA + 25, PHA + 50, PHA + 100: cells incubated with PHA plus 25, 50, and 100 μg/mL TsV, respectively. Each
column represents the mean ± SEM of five experiments. *p < 0.05, **p < 0.01, ***p < 0.001 vs. CFSE
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research to elucidate the action mechanisms involved, in-
cluding the participation of T lymphocyte ion channels in
the phenomena observed.
Conclusions
TsV is a potential immunomodulator of human T
lymphocyte functions. The results reported herein
stimulate further investigations to identify the venom
components responsible for the observed effects and
to elucidate the molecular mechanisms involved in
TsV immunomodulatory action on lymphocytes. These
investigations may facilitate the development of new
tools to study the pathophysiological mechanisms of
envenomation and to discover new treatment alterna-
tives for diseases mediated by the immune system.
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